Indolent Non Follicular Lymphomas Prognostic Project

Indolent B-Cell Lymphomas Clinical Trial

Official title:
Indolent Non Follicular Lymphomas Prognostic Project - Prospective Collection of Data of Possible Prognostic Relevance in Patients With Indolent Non-follicular B-CELL Lymphomas

Status Active, not recruiting

Clinical Trial Summary

Prospective collection of data of possible prognostic relevance in patients with indolent non - follicular B-CELL Lymphomas.

Clinical Trial Description

The present study is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed patients with non-follicular low grade B-cell lymphoma. The study is aimed to verify whether a prognostic collection of data would allow the development of a more accurate prognostic assessment for non-follicular low grade B-cell lymphomas. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02904577
Study type	Observational
Source	Fondazione Italiana Linfomi - ETS
Contact
Status	Active, not recruiting
Phase
Start date	September 2011
Completion date	September 2024

View Details

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT02991638` - Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers	Phase 3
	Completed	`NCT03329950` - A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies	Phase 1